Charles Schwab Investment Management »

Tenax Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Tenax Therapeutics (TENX) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Tenax Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tenax Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tenax Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $890k 61k 14.55

More positions owned by Charles Schwab Investment Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Us L (FNDX)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Micron Technology (MU)
Schwab Strategic Tr Fundamental Intl (FNDF)
Eli Lilly & Co. (LLY)
Home Depot (HD)

View all positions for Charles Schwab Investment Management

Top funds holding Tenax Therapeutics

FMR
T. Rowe Price Associates
Vivo Capital
Henderson Group
BlackRock
Perceptive Advisors
Ikarian Capital
Vanguard Capital Management
Citadel Advisors
Millennium Management
Candriam Luxembourg S.C.A.
Caption Management
Rtw Investments
Stonepine Capital Management
Geode Capital Management

View all funds holding Tenax Therapeutics